Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
Hologic, Inc., (Nasdaq: HOLX) a global leader in women’s health focused on developing innovative medical technologies that effectively detect, diagnose and treat health conditions, today issued the following statement regarding the United States Preventive Services Task Force draft guidelines for cervical cancer screening: "Today’s recommendations are an important acknowledgement of the role of Pap testing combined with HPV testing,